DFW Capital Partners is
pleased to announce that its existing portfolio company, Evolution Research
Group (“ERG”), has acquired Clinical Pharmacology of Miami, LLC (“CPMI”), a clinical
investigative site conducting research protocols for pharmaceutical/biotech
companies and a leader in specialty population Phase I trials. With this
acquisition, ERG has now completed three strategic add-on acquisitions since DFW’s
initial investment in April 2014, and continues to establish itself as the leading
clinical trials provider in the Central Nervous System (“CNS”) space, with an
expanding presence in other specialty populations, and with a consistent focus
on compliance and quality.
Lori Wright, Evolution
Research Group’s CEO, commented, “The addition of CPMI’s highly experienced,
quality-driven team and unique early phase capabilities complements ERG’s
existing service offering on many levels. Importantly, our clients have come to
rely on our expertise not only for the execution of their critical path studies
in highly specialized populations in the field of neuroscience, but also for
assistance in study design and crucial decision making processes along the path
of a compound’s development. With the addition of CPMI, clients now further
benefit from a single point of contact at ERG for all of their early phase
needs through to pharmacology trials typically conducted later in the development
cycle as well.”
The acquisition was completed
with additional debt financing from ERG’s existing lenders, Business Development
Corporation of America and Babson Capital Management.
About DFW Capital Partners
DFW Capital Partners is a private equity investment firm focused on lower
middle-market companies. The firm concentrates on service companies, with an
emphasis on healthcare and outsourced business and industrial support services.
DFW has established a 20+ year track record of success in both building leading
companies, and recognizing outstanding returns for its investors. DFW is
headquartered in Teaneck, NJ, and maintains an office in Chevy Chase, MD. For
more information contact Keith Pennell, Managing Partner, at (201) 836-6000.